Dendritic cell-derived vaccine(CellxLife)

N/A

Report date: 2024/07/12 13:25:25

Base Information

Drug NameDendritic cell-derived vaccine(CellxLife)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSarcoma, EwingOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellxLife
China Registration ClassN/A

Develop Information

Active CompaniesCellxLife
Inactive CompaniesN/A
Active IndicationsSarcoma, EwingOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A